Compare CELH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELH | BIRK |
|---|---|---|
| Founded | 2004 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 5.7B |
| IPO Year | 2008 | 2023 |
| Metric | CELH | BIRK |
|---|---|---|
| Price | $30.62 | $33.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $64.81 | $61.43 |
| AVG Volume (30 Days) | ★ 11.7M | 2.9M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $1,318,014,000.00 | N/A |
| Revenue This Year | $37.04 | $13.71 |
| Revenue Next Year | $9.89 | $14.30 |
| P/E Ratio | $67.35 | ★ $17.48 |
| Revenue Growth | ★ 101.65 | N/A |
| 52 Week Low | $23.56 | $31.33 |
| 52 Week High | $66.74 | $50.73 |
| Indicator | CELH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 35.98 |
| Support Level | $27.39 | $33.06 |
| Resistance Level | $33.84 | $37.29 |
| Average True Range (ATR) | 1.56 | 1.34 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 46.93 | 4.01 |
Celsius Holdings operates in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. It owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It focuses on product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.